Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shikoku Alfresa is a prominent pharmaceutical wholesaler operating primarily in the Shikoku region of Japan. As a core subsidiary of Alfresa Holdings Corporation, the company is responsible for the distribution of ethical pharmaceuticals, medical devices, and diagnostic reagents to a wide network of healthcare institutions, including hospitals and pharmacies. The company was formed through the merger of several regional wholesalers, consolidating its position as a key logistics provider in the area. Shikoku Alfresa focuses on maintaining a stable medical supply chain while providing value-added information services to support healthcare professionals. Its operations are integral to the healthcare infrastructure of Kagawa, Tokushima, Ehime, and Kochi prefectures. The company leverages advanced logistics technology to ensure the safe and efficient delivery of temperature-sensitive medical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shikoku Alfresa.